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Formulation of drug products is a multidisciplinary field, with pharmaceutical 
materials science being a fundamental branch that continuously provides important 
insights, theories, and technologies to formulation sciences. The recent advances in this 
area have brought this research possibility to produce pharmaceutical materials by 
crystallization design. This research is conducted to determine the character by both 
physical and chemical properties beside to determine the solubility of Carbamazepine 
and Saccharin. It is started by determine the co-crystal solubility of Carbamazepine and. 
Saccharin by applying the different concentration and temperature of Carbamazepine 
and Saccharin solution by following gravimetric method. It is proceed by determine the 
characterization of solution by screening using FTIIR, TGA and DSC to get morphology, 
melting point, weight loss and wavelength. The final discussion after result finding, it 
can be concluding that concentration and temperature are the main factor to control the 
solubility of Carbamazepine and Saccharin co-crystal. By using the solubility that was 
obtained from the gravimetric method, the characterization process of both 
Carbamazepine and Saccharin are also conclude by their own properties. As an 
additional conclusion, solid state form of active pharmaceutical ingredients (APIs), co-
crystals not only offer a tool for tailoring physicochemical properties, but also create 
new opportunities for the research-based pharmaceutical companies to address 




Formulasi produk dadah adalah satu bidang pelbagai disiplin, dengan sains 
bahan farmaseutikal menjadi satu cabang asas yang bertemsan memberikan pandangan 
yang penting, teori dan teknologi untuk sains penggubalan. Kemajüan terkini dalam 
bidang mi telah membawa kemungkinan mi penyelidikan untuk menghasilkan bahan-
bahan farmaseutikal oleh reka bentuk penghabluran. Penyelidikan mi dijalankan untuk 
menentukan watak ciri-ciri fizikal dan kimia untuk menentukan kelarutan 
Carbamazepine dan Sakarin. la bermula dengan menentukan keterlarutan bersama 
kristal Carbamazepine dan Sakarin dengan menggunakan berbeza kepekatan dan suhu 
penyelesaian Carbamazepine dan Sakarin dengan mengikuti kaedah gravirnetrik. la 
diteruskan dengan menentukan pencirian penyelesáian oleh saringan menggunakan 
FTIR, TGA dan DSC untuk mendapatkan morfologi, takat lebur, berat badan dan 
panjang gelombang. Perbincangan akhir selepas keputusan ditemui, ia boleh 
disimpulkan bahawa kepekatan dan suhu adalah faktor utama untuk mengawal 
kebolehiarutan kristal bersama Carbamazepine dan Sakarin. Dengan menggunakan 
kebolehiarutan yang diperolehi daripada kaedah gravimetrik, proses pencirian kedua-
dua Carbamazepine dan Sakarin juga boleh didapati berdasarkan kaedah tertentu 
mengikut alatan perincian yang digunakan. Sebagai kesimpulan tambahan, pepejal 
bahan aktif farmaseutikal (API), bersama-kristal bukan sahaja menawarkan alat untuk 
penghasilan sifat fizikokimia, tetapi juga mewujudkan peluang-peluang baru bagi 
syarikat-syarikat farmaseutikal berasaskan penyelidikan untuk menangani harta intelek 
(IP) isu-isu perlindungan.
CHAPTER ONE: INTRODUCTION 
1.1 BACKGROUND STUDY 
Pharmaceutical industry is a rapidly growing industry in line with the interests 
of pharmacy to human health globally. Because of that, chemists and engineers in the 
pharmaceutical industry generally seek to deliver the best effort from them to produce better 
research and development in pharmaceutical especially in crystallization. One flourishing area in 
the field of crystal engineering is based upon the formation of crystalline molecular complexes, 
or co crystals (Nehm, et al. 2006). 
Pharmaceutical co-crystals contain an active pharmaceutical ingredient (API) and at least 
one other co-former, which is normally a solid under ambient conditions. Co crystals may be 
defined as materials which contain two or more discrete molecular entities in the crystal lattice. 
Crystal engineering, when applied to co crystal systems, generally involves the design and study 
of new materials in order to widen the knowledge base of successful engineering strategies, and 
the application of that knowledge to provide co crystals with specific properties for a multitude 
of applications (Braga, 2003). 
Crystal engineering is actively applied within a variety of scientific disciplines' as diverse 
as materials science, nanotechnology and the pharmaceutical industry. Crystal form can be 
crucial to the performance of a dosage form (Nehm, et al. 2006). This is especially true for 
compounds that have intrinsic barriers to drug delivery, such as low aqueous solubility, slow 
dissolution in gastrointestinal media, low permeability and first-pass metabolism. The nature of 
the physical form and formulation tends to exhibit the greatest effect on bioavailability 
parameters of water insoluble compounds that need to be given orally in high doses (Nehm, et al. 
2006).
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An alternative approach available for the enhancement of drug solubility, dissolution and 
bioavailabilitY is through the application of crystal engineering of co-crystals. The 
hysicochemical properties of the active pharmaceutical ingredients and the bulk material 
properties can be modified, whilst maintaining the intrinsic activity of the drug molecule. This 
research covers solid dispersions and pólyrnorphs, mechanism of formation of co-crystals, 
methods of preparation of co-crystals and application of co-crystals to modify physicochemical 
characteristics of active pharmaceutical ingredients along with the experiments. (A Yadav et al., 
2009). 
1.2 RESEARCH OBJECTIVE 
Based on the aforementioned research background and problem statement, the objectives of this 
study are: 
1. To measure the solubility of Carbamazepine(CBZ),Saccharin(SAC) and 
Carbamazepine-Saccharin(CBZ-SAC) co-crystal. 
2. Study the phase transformation of the CBZ-SAC co-crystal.
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1.3 RESEARCH SCOPE 
The scope of the research consists of: 
I) Measurement of CBZ and SAC by using gravimetric and High-Performance Liquid 
Chromatography method. 
2) Manipulation of the SAC ratio to CBZ in order to measure the co-crystal 
transformation based on the solubility data obtained. 
1.4 PROBLEM STATEMENT 
Carbamazepine solubility is very low in the water to react. To come out from this 
problem, co-crystal formation is studied in order to improve the Carbamazepine solubility. 
Before the co-crystal formation experiment is precede, the solubility of carbamazepine and the 
chosen co-crystal former, Saccharin solubility is measured as a guideline calculation and 
selection for further study.
3
REPORT LAY-OUT 
This report contains 5 main chapters to distribute the whole report accordingly. In the 
first chapter, the introduction which gave the biiefing about this project is discussed. The second 
chaptercontaiflS literature review based on crystallization and co-crystal. The third chapter 
expl'ild the methodology of the experiment. In the fourth chapter, it contain results and 
discussions and in final chapter with conclusions and recommendations.
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CHAPTER TWO: LITERATURE REVIEW 
2.1 FUNDAMENTALS OF CRYSTALLIZATION AND CO- CRYSTAL 
2.1.1 CRYSTALLIZATION 
Crystallization is another -solid-liquid separation process,in which mass-transfer of a 
solute from the liquid solution to a pure solid crystalline phase occurs. An important example is 
in the production of sucrose from sugar beet,where the sucrose is crystallized out from an 
aqueous solution (Geankoplis, 2003). 
Crystallization is a process where solid particles are formed from homogenous phase. 
This process can occur in freezing of water to form ice, in the formation of snow particles from a 
vapor, in the formation of solid particles from a liquid melt,or in the formation of solid crystals 
from liquid solutions. In crystallization the solution is concentrated and usually cooled until the 
solute concentration become greater than its solubility at that temperature. The solute comes out 
of the solution, forming crystals of approximately pure solute (Geankoplis., 2003). 
2.1 .1 .1 Types of Crystal Geometry. 
A crystal can be defined as a solid composed of atoms ions, or molecules which are 
arranged in an orderly and repetitive manner. It is a highly organized types of matter. The atom, 
ions, or molecules are located in three-dimensional arrays or space lattices. The interatomic 
distances between these imaginary plane or spaces lattices in a crystal are measured by X-ray 
diffraction, are the angles between these planes. The pattern or arrangement of these space 
lattices is repeated in all direction (Geankoplis, 2003).
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There are seven classes of crystal, depending upon the arrangement of the axes to which 
the angles are referred: 
1) Cubic system. Three equals axes at right angles to each other. 
2) Tetragonal system. Three axes at right angles to each other, one axis longer than the other 
two. 
3) Orthorhombic system. Three axes at right angles to each other, all of different length. 
4) Hexagonal system. Three equal axes in one plane at 600 to each other, and fourth axis at 
right angle to this plane and not necessarily at the same length. 
5) Monoclinic system. Three unequal axes, two at right angles in plane and a third at some 
angle to this plane. 
6) Triclinic system. Three unequal axes at unequal angles to each other and not 30,60, or 90. 
7) Trigonal system. Three equal and equally inclined axes. 
The relative development of different types of faces of a crystal may differ depending on the 
solute crystallizing.
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2.1.1.2 Equilibrium Solubility in Crystallization 
Once crystallization is concluded, equilibrium is set up between the crystals of pure 
solute and the residual mother liquor, the balance being determined by the solubility 
(concentration) and the temperature. The driving force making the crystals grow is the 
concentration excess (supersaturation) of the solution above the equilibrium (saturation) level. 
The resistances to growth are the resistance to mass transfer within the solution and the energy 
needed at the crystal surface for incoming molecules to orient themselves to the crystal lattice 
(Earle, 1983). 
Solubility is defined as the maximum weight of anhydrous solute that will dissolve in IOU 
g of solvent. In the food industry, the solvent is generally water (Earle, 1983). 
During crystallization, the crystals are grown from solutions with concentrations higher 
than the saturation level in the solubility curves. Above the supersaturation line, crystals form 
spontaneously and rapidly, without external initiating action. This is called 
spontaneous nucleation. In the area of concentrations between the saturation and the 
supersaturation curves, the metastable region, the rate of initiation of crystallization is slow; 
aggregates of molecules form but then disperse again and they will not grow unless seed crystals 
are added. Seed crystals are small crystals, generally of the solute, which then grow by 
deposition on them of further solute from the solution. This growth continues until the solution 
concentration falls to the saturation line. Below the saturation curve there is no crystal growth, 
crystals instead dissolve (Earle, 1983). 
The solubility of a substance is dependent on the forces holding the crystal together (the 
lattice energy) and the solvent acting on these forces. For now, we will consider only water as 
the solvent. As the solid dissolves, water molecules surround the ions in the solution by a 
process called hydration. During hydration, energy is released. The extent to which the energy 
of hydration is greater than the lattice energy determines the solubility (Earle, 1983).
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The equilibrium involved in the solubility of a substance is: 
MaXb (s)	 a	 (aq) + b X (aq) (a general equation)
	 (2.1) 
where M is the cation of change n+ and X is the anion of charge n-. The subscripts of the salt 
become the coefficients for the ions. The equilibrium mass action expression would be: 
KsP= [M]a [X1]b	 (2.2) 
Notice that only the aqueous ions are part of the mass action expression. Solids are never 
included. Also notice that the coefficient for each ion becomes the exponent in-the mass- action 
expression. 
There are four common types of solubility equilibria problems: solubility in pure water 
(will a precipitate form or finding the molar solubility), solubility in the presence of a common 
ion and selective precipitation. 
2.1.1.3 Equipment for Crystallization. 
Crystallizer may be classified according to whether they are batch or continuos in 
operation. Batch operation is done for certain special application. Continuous operation of 
crystallizers is generally preferred (Geankoplis, 2003). 
Crystallization cannot occur without super-saturation. A main function of any crystallizer 
is to cause a supersaturated solution to form. Crystallizing equipment can be classified according 
to the methods used to bring about super-saturation as follows; 
I) Super-saturation produced by cooling the solution with negligible evaporation-tank and 
batch-type crystallizer 
2) Super-saturation produced by evaporation of the solvent with little or no cooling-
evaporatorrystallizers and crystallizing evaporators.
KQ
3) Super-saturation by combined cooling and evaporation in an-adiabatic evaporator-
vacuum crystallizer. 
In another method of classification of crystallizers, the equipment is classified according 
to the method of suspending the product crystal. Examples are crystallizer where the suspension 
is agitated in a tank, is circulated by a heat exchanger, or is circulated in a scrapped surface 
exchanger (Geankoplis, 2003). 
Tank crystallizer. 
In tank crystallization, which is an old method is still used in some specialized cases, hot 
saturated solution is allowed to cool in open tanks. After a period of time the mother liquor is 
drained and the crystals removed. Nucleation and the size of crystals are difficult to control. 
Crystals contain considerable amounts of occluded mother liquior. Labor cost is very high. In 
some cases the tank is cooled by coils or a jacket and an agitation used to improved heat-transfer 
rate. However, crystal often builds up on these surfaces. This type of crystallizers has limited 
application; it is sometimes used to produce certain fine chemicals and pharmaceuticals products 
(Geankoplis, 2003). 
Scraped surface crystallizers 
One type of scraped surface crystallizers is the Swenson-Walker crystallizer, which 
consist of an open through 0.6 m wide with a semicircular bottom having a cooling jacket 
outside. A slow-speed spiral agitator rotates and suspends the growing crystals on turning. The 
blades pass closed to the wall and break-off any deposits of crystals on the cooled wall. The 




Figure 2.1 Image of Circulating-liquid evaporator-crystallizer by Swenson-equip. 
From Figure 2.1, these crystallizers combine crystallization and evaporation, thus the 
driving forces toward supersaturation. The circulating liquid is forced through the tubeside of a 
steam heater. The heated liquid flows into the vapor space of the crystallization vessel. Here, 
lash evaporation occurs, reducing the amount of solvent in the solution (increasing solute 
concentration), thus driving the mother liquor towards supersaturation. The supersaturated 
liquor flows down through a tube, then up through a fluidized area of crystals and liquor where 
crystallization takes place via secondary nucleation. Larger product crystals are withdrawn 
while the liquor is recycled, mixed with the feed, and reheated (Geankoplis, 2003).
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Circulating - magma vacuum crystallizer 
Figure 2.2 Image of Circulating-magma Vacuum Crystallizer by Swenson-equip.com 
Figure 2.2 shows the example of Circulating-magma Vacuum Crystallizer. In this type of 
crystallizer, the crystal/solution mixture (magma) is circulated out of the vessel body. The 
magma is heated gently and mixed back into the vessel. A vacuum in the vapor space cause 
boiling at the surface of the liquid. The evaporation causes crystallization and the crystals are 
drawn off near the bottom of the vessel body (Geankoplis, 2003).
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Evaporative crystallizers 
Evaporative crystallizers are common in the sugar and salt industries. They are generally 
of the calandria type. Vacuum evaporators are often used for crystallization as well, though 
provision needs to be made for handling the crystals. Control of crystal size can be obtained by 
careful manipulation of the vacuum and feed. The evaporator first concentrates the sugar 
solution, and when seeding commences the vacuum is increased. This increase causes further 
evaporation of water which cools the solution and the crystals grow. Fresh saturated solution is 
added to the evaporator and evaporation continued until the crystals are of the correct size. In 
some cases, open pan steam-heated evaporators are still used, for example in making coarse salt 
for the fish industry. In some countries, crystallization of-salt-from  sea water is effected by solar 
energy which concentrates the water slowly and this generally gives large crystals (Earle, 1983). 
2.1.2 CO-CRYSTAL 
2.1.2.1 Co-crystal Design 
Co-crystals are multiple component systems where intermolecular interactions (including 
hydrogen bonds, van der Waals, and it - it interactions) and favorable geometries lead to a self-
assembled supramolecular network. Co-crystals offer the advantage of generating solid forms of 
APIs even when they lack ionizable functional groups and in this way produce materials with a 
large range of properties that are not available in single API solid phases (polymorphs and 
amorphous forms), or in API solvates, or salt forms. Solvates are com pounds where one of the 
components is liquid at room temperature, such as a hydrate. In a crystalline salt, the interactions 
are mostly electrostatic, and the components are ionized (Childs, et al. 2008). 
A pharmaceutical co-crystal contains an API and a co-former molecule(s), both of which 
typically exist in the neutral state and interact by hydrogen bonding or by other non-covalent 
bonds. (A few co-crystals have been synthesized in which the API is ionized, but the co-former 
is still non-ionized (Childs and Hardcastle, 2007).) The term co-crystal generally refers to 
components that in their pure states are solids at room temperature (Aakeroy and Salmon, 2005). 
Co-crystals may include two or more different components and in most cases to date, two and 
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three component systems are reported with the latter being mostly co-crystalline solvates, e.g.

hydrate (Zaitu, et al. 1995), carbamazepine-4-aminobenzoic acid

hydrate (McMahon, Bis et al. 2005), and tetroxoprim-sulfametrole methanolate (Caira, et al. 
2003).
The field of crystal engineering has focused on understanding the intermolecular 
interactions and connectivity that lead to the construction of super molecules or extended 
architectures. Because of its strength and directionality, the hydrogen bond has been the most 
important interaction in co-crystal formation (Wenger and Bernstein, 2008). By studying the 
hydrogen bond patterns in crystalline solids, valuable knowledge is gaining to identify hydrogen-
bond preferences and reliable synthons that lead--to co-crystal formation -(Wenger and Bernstein 
2008). The frequency of hydrogen bond motifs and other important interactions in crystal 
lattices can be studied by using the Cambridge Structural Database (CSD) by searching for 
specific molecules, functional groups, and synthons (Nangia and Desiraju, 1998). 
2.1.2.2 Carbamazepine Co-Crystal Structure
0 
Figure 2.3 Chemical Structure of Carbamazepine
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